The DHM is an interdisciplinary meeting, bringing together researchers and physicians from different disciplines and different parts of world, to exchange their most up-to-date data in the continually evolving field of drug hypersensitivity, and to transfer them into clinical practice. It is the leading event of its kind, attracting up to 600 physicians and researchers.
The meeting includes plenary lectures, parallel symposia, pro-con debate sessions, breakfast seminars, and clinical cases.
The scientific program covers a wide range of topics related to drug hypersensitivity in both basic science and clinical research and in immediate and delayed type hypersensitivity.
Again, we will discuss the most recent and topical challenges in our day-to-day practice. This includes the checkpoint inhibitors and the role of genetics, epigenetics and enzymes, and old challenges such as hypersensitivity to antibiotics and anaesthetics, along with the mechanisms of hypersensitivity reactions.